Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,750,000
Closed -$176M 62
2025
Q2
$176M Buy
1,750,000
+1,495,249
+587% +$114M 5.65% 5
2025
Q1
$19.4M Buy
+254,751
New +$19.5M 0.63% 39
2024
Q3
Sell
-2,000,000
Closed -$134M 77
2024
Q2
$134M Sell
2,000,000
-2,783,679
-58% -$108M 4% 6
2024
Q1
$130M Sell
4,783,679
-566,321
-11% -$15.8M 3.72% 4
2023
Q4
$166M Sell
5,350,000
-650,000
-11% -$16.9M 5.54% 1
2023
Q3
$152M Sell
6,000,000
-500,000
-8% -$11.4M 5.85% 1
2023
Q2
$137M Hold
6,500,000
6.35% 2
2023
Q1
$111M Buy
6,500,000
+2,235,708
+52% +$43.4M 4.55% 5
2022
Q4
$85.2M Buy
+4,264,292
New +$82.4M 3.58% 6

Other funds holding INSM

Deep Track Capital's INSM Position: Q3 2025 in Review

Deep Track Capital sold out of Insmed (INSM) in Q3 2025, closing a stake of 1,750,000 shares — an estimated $176M sold.

Deep Track Capital first reported a position in INSM in Q4 2022 and held it in 9 quarters. The position peaked at $176M in Q2 2025. 566 funds tracked by Wall St. Rank hold INSM as of Q3 2025.

  • Deep Track Capital reported no remaining Insmed position as of Q3 2025 after selling out during the quarter.
  • Deep Track Capital sold 1,750,000 Insmed shares in Q3 2025, an estimated $176M.
  • Deep Track Capital first reported a position in Insmed in Q4 2022 and held it in 9 quarters.
  • Deep Track Capital's Insmed position peaked at $176M in Q2 2025.
  • 566 funds tracked by Wall St. Rank held Insmed as of Q3 2025.

Based on Deep Track Capital's 13F filing for Q3 2025, filed 14 Nov 2025.